Animal studies on Selzentry and pregnancy have shown that the medication does not appear to harm the fetus. However, animals do not always respond to drugs in the same way as humans. Therefore, if you are taking Selzentry and pregnancy occurs, your healthcare provider will have you continue the medication only if the benefits outweigh the possible risks.
Selzentry and Pregnancy: An Overview
Selzentry™ (
maraviroc) is a prescription
HIV medication. Studies involving pregnant animals have shown that the drug appears to be safe for use during pregnancy, although adequate human studies have not been conducted.
Selzentry and Pregnancy Category B
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is given to medicines that have not been studied in pregnant humans but that do not appear to cause harm to the fetus in animal studies.
However, it is important to note that animals do not always respond to medicines in the same way that humans do. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if her healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child.
Selzentry and Pregnancy: Final Thoughts
If you are pregnant, it is always a good idea to talk to your healthcare provider before taking any medication. You and your healthcare provider can consider the possible risks and benefits of using Selzentry in your particular situation, as well as any other treatment alternatives. Women who have HIV need special
prenatal care, both for themselves and to prevent the transmission of HIV to their babies.
Add this article to your Favorites
Email this article
Print